002550.SZ
002550.SZ
CNE100001070
QIANHONG BIO-PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.571.276.512 1.526.242.787
3.0%
Cost of Revenue 654.347.578 689.067.136
5.0%
Gross Profit 916.928.934 837.175.651
9.5%
584.418.743 542.694.019
7.7%
Operating Income 332.510.191 294.481.632
12.9%
Pretax Income 450.181.946 395.838.975
13.7%
Net Income Common Stockholders 398.795.540 356.032.007
12.0%
-- --
--
-- --
--
ende